Enterprise Value

788.6M

Cash

525.9M

Avg Qtr Burn

-19.24M

Short % of Float

31.16%

Insider Ownership

3.50%

Institutional Own.

-

Qtr Updated

03/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
4D-150 Details
Diabetic macular edema

Phase 2

Data readout

4D-150 Details
Wet age-related macular degeneration

Phase 2

Data readout

4D-310 Details
Fabry disease

Phase 1/2

Data readout

4D-125 Details
X-linked retinitis pigmentosa

Phase 1/2

Data readout

4D-710 Details
Cystic fibrosis

Phase 1/2

Data readout

4D-110 Details
Choroideremia

Phase 1

Data readout

4D-175 Details
Geographic atrophy

IND

Submission